Product
SpikoGen
Aliases
Covax-19, SpikoGen vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Immunogenicity and Safety Study in Ambulatory Adults of a Single Intramuscular Dose of SpikoGen Vaccine as a Heterologous or Homologous Booster Dose Following Completion of a Primary Course of Covid-19 VaccineStatus: Active (not recruiting), Estimated PCD: 2023-12-31